Inoviq Ltd (AU:IIQ) has released an update.
INOVIQ Limited has issued 750,000 new shares at A$0.50 each, utilizing its existing placement capacity, as detailed in a notice compliant with section 708A(5)(e) of the Corporations Act. The biotech firm, known for its innovative diagnostics and therapeutics for cancer, including its EXO-NET exosome isolation technology and hTERT test for bladder cancer, ensures all necessary legal and information disclosure requirements have been met.
For further insights into AU:IIQ stock, check out TipRanks’ Stock Analysis page.
